• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹病毒VP16和jun的嵌合体具有致癌性。

Chimeras of herpes simplex viral VP16 and jun are oncogenic.

作者信息

Schuur E R, Parker E J, Vogt P K

机构信息

Department of Microbiology, University of Southern California School of Medicine, Los Angeles.

出版信息

Cell Growth Differ. 1993 Sep;4(9):761-8.

PMID:8241024
Abstract

The Jun protein binds DNA and regulates transcription as a component of the AP-1 transcription factor complex. In its oncogenic form, Jun can transform cells in culture and cause tumors in animals. Both trans-activation and transformation require several functional domains of Jun, including an amino-terminal trans-activation domain. In this study, properties of Jun required for trans-activation and transformation were explored by replacing the trans-activation domains of c-Jun and its oncogenic counterpart, v-Jun, with the constitutively active trans-activation domain from the herpes simplex virus VP16 protein. The VP16-v-Jun chimera retained similar oncogenic properties to its parent, v-Jun. The VP16-c-Jun chimera, however, was considerably more oncogenic than c-Jun. Substitutions of a phenylalanine in the VP16 domain of the VP16-c-Jun chimera diminished or abolished transformation. Each of the chimeras bound to the AP-1 consensus recognition sequence from the collagenase promoter or from the human T-cell leukemia virus type I long terminal repeat in vitro. None of the VP16-Jun chimeras efficiently stimulated transcription from the collagenase promoter or an artificial promoter containing the human T-cell leukemia virus type I element in vivo. These results demonstrate that the Jun trans-activation domain can be replaced by a heterologous trans-activation domain with retention of oncogenic activity. However, this oncogenic activity is not reflected in the trans-activating properties of the chimeras.

摘要

Jun蛋白作为AP-1转录因子复合物的一个组成部分,可结合DNA并调节转录。在其致癌形式中,Jun可在培养物中转化细胞并在动物体内引发肿瘤。反式激活和转化都需要Jun的几个功能结构域,包括一个氨基末端反式激活结构域。在本研究中,通过用单纯疱疹病毒VP16蛋白的组成型活性反式激活结构域替换c-Jun及其致癌对应物v-Jun的反式激活结构域,探索了反式激活和转化所需的Jun的特性。VP16-v-Jun嵌合体保留了与其亲本v-Jun相似的致癌特性。然而,VP16-c-Jun嵌合体比c-Jun的致癌性要强得多。在VP16-c-Jun嵌合体的VP16结构域中用苯丙氨酸替代会减弱或消除转化作用。每个嵌合体在体外均与来自胶原酶启动子或人I型T细胞白血病病毒长末端重复序列的AP-1共有识别序列结合。在体内,没有一个VP16-Jun嵌合体能够有效地刺激来自胶原酶启动子或含有I型人T细胞白血病病毒元件的人工启动子的转录。这些结果表明,Jun反式激活结构域可以被异源反式激活结构域取代,并保留致癌活性。然而,这种致癌活性并未体现在嵌合体的反式激活特性中。

相似文献

1
Chimeras of herpes simplex viral VP16 and jun are oncogenic.单纯疱疹病毒VP16和jun的嵌合体具有致癌性。
Cell Growth Differ. 1993 Sep;4(9):761-8.
2
Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.人工癌蛋白:酵母碱性亮氨酸拉链蛋白GCN4的修饰版本可诱导细胞转化。
Oncogene. 2003 Sep 11;22(39):7931-41. doi: 10.1038/sj.onc.1206527.
3
Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.单纯疱疹病毒1型VP16的DNA结合衍生物(缺乏羧基末端酸性激活结构域)的转录激活作用。
Virology. 1995 May 10;209(1):19-28. doi: 10.1006/viro.1995.1227.
4
Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.v-Jun碱性结构域的定向突变改变了DNA结合特异性,并消除了其在鸡胚成纤维细胞中的致癌活性。
Oncogene. 2000 Oct 5;19(42):4876-85. doi: 10.1038/sj.onc.1203863.
5
TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).TOJ3是v-Jun转录因子的一个靶点,编码一种与人类微球蛋白1(MCRS1)相关的具有转化活性的蛋白质。
Oncogene. 2001 Nov 8;20(51):7524-35. doi: 10.1038/sj.onc.1204938.
6
In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.体内病毒和细胞的Jun复合物与许多体外产生的“AP-1样”和“CREB样”靶序列表现出不同的相互作用。
Oncogene. 1993 Jul;8(7):1895-903.
7
Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.Tat与VP16在HIV-1长末端重复序列反式激活中的协同作用。
J Mol Biol. 1993 Dec 5;234(3):610-9. doi: 10.1006/jmbi.1993.1615.
8
Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Oncogene. 1993 May;8(5):1135-40.
9
The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.v-Myc和VP16的转录激活结构域与细胞转化和增殖所需的共同因子相互作用。
Cell Growth Differ. 1994 Jun;5(6):563-73.
10
JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.JAC是致癌转录因子Jun的直接靶点,参与细胞转化和肿瘤发生。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13601-6. doi: 10.1073/pnas.241451198. Epub 2001 Nov 6.

引用本文的文献

1
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.肝素结合表皮生长因子样生长因子,一种v-Jun靶基因,可诱导致癌转化。
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5716-21. doi: 10.1073/pnas.96.10.5716.
2
Transcription factor ATF2 cooperates with v-Jun to promote growth factor-independent proliferation in vitro and tumor formation in vivo.转录因子ATF2与v-Jun协同作用,以促进体外不依赖生长因子的增殖及体内肿瘤形成。
Mol Cell Biol. 1998 Dec;18(12):7020-9. doi: 10.1128/MCB.18.12.7020.
3
Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera.
由Jun-雌激素受体嵌合体诱导的激素可调节的肿瘤转化。
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12396-400. doi: 10.1073/pnas.94.23.12396.
4
Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells.由腺病毒载体表达的组成型类视黄醇受体,其特异性激活早幼粒细胞白血病和畸胎癌细胞分化所需的染色体靶基因。
J Virol. 1996 Oct;70(10):7182-9. doi: 10.1128/JVI.70.10.7182-7189.1996.